Literature DB >> 11159956

Modulation of cytokine release in ex vivo-stimulated blood from borreliosis patients.

I Diterich1, L Härter, D Hassler, A Wendel, T Hartung.   

Abstract

In lipopolysaccharide-stimulated blood from 71 late-stage borreliosis patients, the ex vivo cytokine release capacity of tumor necrosis factor alpha (TNF-alpha) and gamma interferon (IFN-gamma) was reduced to 28% +/- 5% and to 31% +/- 5% (P < or = 0.001), respectively, compared to that of 24 healthy controls. White blood cell counts were normal in both groups. To investigate direct interactions between the pathogen and the immune cells, blood from healthy controls was exposed in vitro to live or heat-killed Borrelia or to Borrelia lysate. Compared to the pattern induced by bacterial endotoxins, a reduced release of TNF-alpha and IFN-gamma and an enhanced secretion of interleukin-10 and granulocyte colony-stimulating factor was found. In blood from 10 borreliosis patients stimulated with Borrelia lysate, TNF-alpha formation was decreased to 31% +/- 14% and IFN-gamma formation was decreased to 8% +/- 3% (P < or = 0.001) compared to the cytokine response of blood from healthy controls (n = 24). We propose to consider anti-inflammatory changes in the blood cytokine response capacity elicited by Borrelia as a condition that might favor the persistence of the spirochete.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11159956      PMCID: PMC97940          DOI: 10.1128/IAI.69.2.687-694.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  41 in total

1.  Effect of filgrastim treatment on inflammatory cytokines and lymphocyte functions.

Authors:  T Hartung; W D Doecke; D Bundschuh; M A Foote; F Gantner; C Hermann; A Lenz; S Milwee; B Rich; B Simon; H D Volk; S von Aulock; A Wendel
Journal:  Clin Pharmacol Ther       Date:  1999-10       Impact factor: 6.875

2.  [Comparative studies of the differentiation of Pappenheim-Wright stained blood smears in the diagnosis of leukosis].

Authors:  A Tolle; E Schaal; H D Jahnke
Journal:  Zentralbl Veterinarmed B       Date:  1966-02

3.  [Blood picture changes in erythema chronicum migrans].

Authors:  K Weber; O Braun-Falco
Journal:  Hautarzt       Date:  1974-12       Impact factor: 0.751

4.  Structures in Bacillus subtilis are recognized by CD14 in a lipopolysaccharide binding protein-dependent reaction.

Authors:  X Fan; F Stelter; R Menzel; R Jack; I Spreitzer; T Hartung; C Schütt
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

5.  Lyme disease spirochetes induce human and murine interleukin 1 production.

Authors:  G S Habicht; G Beck; J L Benach; J L Coleman; K D Leichtling
Journal:  J Immunol       Date:  1985-05       Impact factor: 5.422

6.  Expression of interleukin-10 activity by Epstein-Barr virus protein BCRF1.

Authors:  D H Hsu; R de Waal Malefyt; D F Fiorentino; M N Dang; P Vieira; J de Vries; H Spits; T R Mosmann; K W Moore
Journal:  Science       Date:  1990-11-09       Impact factor: 47.728

7.  Absence of lipopolysaccharide in the Lyme disease spirochete, Borrelia burgdorferi.

Authors:  K Takayama; R J Rothenberg; A G Barbour
Journal:  Infect Immun       Date:  1987-09       Impact factor: 3.441

Review 8.  Lyme disease.

Authors:  A C Steere
Journal:  N Engl J Med       Date:  1989-08-31       Impact factor: 91.245

9.  Erythema chronicum migrans in Sweden: clinical manifestations and antibodies to Ixodes ricinus spirochete measured by indirect immunofluorescence and enzyme-linked immunosorbent assay.

Authors:  G Stiernstedt; G Eriksson; W Enfors; H Jörbeck; B Svenungsson; B Sköldenberg; M Granström
Journal:  Scand J Infect Dis       Date:  1986

10.  Lack of endotoxin in Borrelia hispanica and Treponema pallidum.

Authors:  P H Hardy; J Levin
Journal:  Proc Soc Exp Biol Med       Date:  1983-10
View more
  15 in total

1.  Critical evaluation of urine-based PCR assay for diagnosis of Lyme borreliosis.

Authors:  Carolin Rauter; Markus Mueller; Isabel Diterich; Sabine Zeller; Dieter Hassler; Thomas Meergans; Thomas Hartung
Journal:  Clin Diagn Lab Immunol       Date:  2005-08

2.  Identification of Borrelia burgdorferi ribosomal protein L25 by the phage surface display method and evaluation of the protein's value for serodiagnosis.

Authors:  Markus Mueller; Sebastian Bunk; Isabel Diterich; Michael Weichel; Carolin Rauter; Dieter Hassler; Corinna Hermann; Reto Crameri; Thomas Hartung
Journal:  J Clin Microbiol       Date:  2006-10       Impact factor: 5.948

3.  Interleukin-10 alters effector functions of multiple genes induced by Borrelia burgdorferi in macrophages to regulate Lyme disease inflammation.

Authors:  Aarti Gautam; Saurabh Dixit; Mario T Philipp; Shree R Singh; Lisa A Morici; Deepak Kaushal; Vida A Dennis
Journal:  Infect Immun       Date:  2011-09-26       Impact factor: 3.441

4.  Lipoprotein-dependent and -independent immune responses to spirochetal infection.

Authors:  Juan C Salazar; Constance D Pope; Meagan W Moore; Jonathan Pope; Thomas G Kiely; Justin D Radolf
Journal:  Clin Diagn Lab Immunol       Date:  2005-08

5.  Distribution of clinically relevant Borrelia genospecies in ticks assessed by a novel, single-run, real-time PCR.

Authors:  Carolin Rauter; Rainer Oehme; Isabel Diterich; Matthias Engele; Thomas Hartung
Journal:  J Clin Microbiol       Date:  2002-01       Impact factor: 5.948

6.  Autocrine and exocrine regulation of interleukin-10 production in THP-1 cells stimulated with Borrelia burgdorferi lipoproteins.

Authors:  Guillermo H Giambartolomei; Vida A Dennis; Barbara L Lasater; P K Murthy; Mario T Philipp
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

7.  Interleukin-10 (IL-10) inhibits Borrelia burgdorferi-induced IL-17 production and attenuates IL-17-mediated Lyme arthritis.

Authors:  Emily S Hansen; Velinka Medić; Joseph Kuo; Thomas F Warner; Ronald F Schell; Dean T Nardelli
Journal:  Infect Immun       Date:  2013-09-16       Impact factor: 3.441

8.  Pattern of proinflammatory cytokine induction in RAW264.7 mouse macrophages is identical for virulent and attenuated Borrelia burgdorferi.

Authors:  Guiqing Wang; Mary M Petzke; Radha Iyer; Hongyan Wu; Ira Schwartz
Journal:  J Immunol       Date:  2008-06-15       Impact factor: 5.422

9.  Borrelia burgdorferi-induced tolerance as a model of persistence via immunosuppression.

Authors:  Isabel Diterich; Carolin Rauter; Carsten J Kirschning; Thomas Hartung
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

10.  Stimulated Immune Response by TruCulture® Whole Blood Assay in Patients With European Lyme Neuroborreliosis: A Prospective Cohort Study.

Authors:  Mathilde Ørbæk; Rosa Maja Møhring Gynthersen; Helene Mens; Christian Stenør; Lothar Wiese; Christian Brandt; Sisse Rye Ostrowski; Susanne Dam Nielsen; Anne-Mette Lebech
Journal:  Front Cell Infect Microbiol       Date:  2021-05-10       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.